Atul Ltd 2009-10

120 / Atul Ltd | Annual Report 2009-10 5 Details of associates considered in consolidation: (Rs crores) Name of associate Country of incorporation Main activities Ownership interest and voting power Original cost of investments Amount of goodwill / capital reserve included in original cost Accumulated Loss at the year end March 31, 2009 Carrying amount of investments at the year end (see Note (1) below) 1 2 3 4 5 6 7 8 (a) Amal Ltd India Dye Intermediates 36.75% 5.15 - 55.61 0.24 (b) Gujarat Synthwood Ltd India PVC sheets and Panels 34.64% 1.30 - 17.08 0.07 (c) AtRo Ltd India Agrochemicals 50.00% 0.50 - 0.43 0.50 (d) Atul Bioscience Ltd India Pharmaceuticals 28.00% - 3.85 6.95 - 76.97 0.81 Note: (i) After provision for diminution in value of investments in case of 'a' and 'b'. (ii) Value of investment in Atul Bioscience Ltd under column '5' and '8' is Rs 140 6 Deferred Tax adjustments recognised in the financial statements: (Rs crores) Particulars Balance As at March 31, 2010 Charge | credit Balance As at March 31, 2009 During the year Deferred tax liabilities: On account of timing difference in (a) Depreciation | impairment loss 29.05 (1.94) 30.99 29.05 (1.94) 30.99 Deferred tax assets: On account of timing difference in (a) Provision for leave encashment 4.36 0.22 4.14 (b) 43 B expenses allowable 0.42 (0.19) 0.61 (c) Provision for doubtful debts - (2.28) 2.28 (d) Provision for doubtful advances 0.06 (3.39) 3.45 (e) Payment under VRS 1.63 (1.16) 2.79 6.47 (6.80) 13.27 22.58 4.86 17.72 (f) Deferred tax assets of subsidiaries (0.01) (0.01) (0.01) Net deferred tax liability | (assets) 22.57 4.85 17.71 Schedule forming part of the Consolidated accounts SCHEDULE 16 NOTES FORMING PART OF THE CONSOLIDATED ACCOUNTS (contd) 121